ACD - a Bio-Techne Brand is a leader in the emerging field of molecular pathology, developing cell- and tissue-based assays and diagnostic tests for personalized medicine.
ACD’s products and services to academia, pharmaceutical and biotechnology companies are based on its proprietary RNAscope® technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
Location: United States, California, Newark
Member count: 51-200
Phone: +1 510-576-8800
Total raised: $34M
Founded date: 2006
Investors 1
Date | Name | Website |
- | New Leaf V... | nlvpartner... |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
18.06.2015 | Series C | $22M | - | finsmes.co... |
01.11.2012 | Series B | $12M | - | vcnewsdail... |
Mentions in press and media 7
Date | Title | Description | Category | Author | Source |
18.06.2015 | Precision ... | Among others, it’s interested ... | - | - | medcitynew... |
18.06.2015 | Advanced C... | Advanced Cell Diagnostics, Inc... | USA | - | finsmes.co... |
01.11.2012 | Advanced C... | Advanced Cell Diagnostics Inc.... | funding U... | - | finsmes.co... |
01.11.2012 | Advanced C... | HAYWARD, CA, World leader in... | - | - | vcnewsdail... |
07.12.2009 | Advanced C... | Share Share on Facebook Share ... | - | Luke Timme... | xconomy.co... |
02.09.2009 | Advanced C... | Advanced Cell Diagnostics has ... | USA ventu... | - | finsmes.co... |
- | Precision ... | Bay Area startup Advanced Cell... | - | - | medcitynew... |